TEM vs RXRX
TEM 与 RXRX 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | TEMTempus AI, Inc. | RXRXRecursion Pharmaceuticals, Inc. |
|---|---|---|
| 市值 | $14.83M | $2.06B |
| 市净率 | 0.03 | — |
| 市销率 | 0.0x | 28.6x |
| 营收 | $1.51B(TTM) | — |
| 营收同比增长 | 83.4% | 26.9% |
| 净利润 | -$189.27M(TTM) | — |
| 净利同比增长 | 65.3% | -39.1% |
| 每股收益(稀释) | $-1.06(TTM) | — |
| 息税前利润率 | -19.9% | -867.9% |
| 净资产收益率 | -49.0% | -70.5% |
| 投入资本回报率 | — | -175.2% |
| 一年总回报 | -12.0% | -27.5% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:TEM vs RXRX
| 指标 | TEM | RXRX |
|---|---|---|
| 期末价值 | $20.4K | $4.2K |
| 总回报 | +104.1% | -58.5% |
| 年化收益 (CAGR) | +34.9% | -30.8% |
| 波动率 | 97.3% | 84.4% |
| 夏普比率 | 0.74 | -0.07 |
| 索提诺比率 | 1.19 | -0.11 |
| 最大回撤 | -59.8% | -73.9% |
基于 598 个共同交易日,2024-06-14 → 2026-11-02 · 无风险利率 4.16%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)